GlassScriptPhysician profile
Christopher M Purmer
NPI 1124058169
$21,362.35
in general payments reported to CMS, 2019-2025
49 companies · $2,901 in 2025
The $2,901 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,148 · 2020: $2,704 · 2021: $3,826 · 2022: $3,266 · 2023: $2,829 · 2024: $2,688 · 2025: $2,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,418.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,029.12 | 2019-2025 | Repatha, Repatha, Tepezza |
| Novartis Pharmaceuticals Corporation | $1,703.71 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,686.28 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Biotronik INC. | $1,117.29 | 2022-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Abbott Laboratories | $1,113.79 | 2019-2024 | Mitraclip, Navitor |
| Merck Sharp & Dohme LLC | $1,019.10 | 2021-2025 | Verquvo |
| Medtronic, INC. | $986.80 | 2021-2025 | Affera Mapping System, Corevalve Evolut R, Micra |
| E.R. Squibb & Sons, L.L.C. | $955.47 | 2019-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $901.54 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $889.71 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $821.08 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $720.92 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $621.32 | 2019-2024 | Lifevest |
| Esperion Therapeutics, INC. | $619.38 | 2020-2025 | Nexletol |
| Pfizer INC. | $606.17 | 2020-2025 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $584.93 | 2019-2025 | Watchman Access System, Bodyguardian |
| Boehringer Ingelheim Pharmaceuticals, INC. | $584.29 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $495.57 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Alnylam Pharmaceuticals INC. | $484.67 | 2021-2025 | Amvuttra, Onpattro |
| Arbor Pharmaceuticals, INC. | $399.54 | 2019-2021 | |
| Astellas Pharma US INC | $378.31 | 2019-2022 | |
| Medtronic Vascular, INC. | $332.58 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $319.57 | 2019-2023 | Livalo |
| Kiniksa Pharmaceuticals, LTD. | $226.71 | 2021-2023 | Arcalyst |
| Lundbeck LLC | $208.15 | 2019-2020 | |
| Bridgebio Pharma, INC. | $192.07 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $185.25 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $164.41 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $142.01 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Regeneron Healthcare Solutions, INC. | $128.35 | 2019-2023 | Evkeeza |
| Cvrx, INC. | $103.56 | 2023-2025 | Barostim Neo System |
| Cleerly, INC. | $100.15 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Actelion Pharmaceuticals US, INC. | $87.01 | 2019-2021 | |
| Irhythm Technologies, INC. | $65.25 | 2021-2023 | Zio Xt Patch |
| Itamar Medical INC | $49.88 | 2022-2023 | Watchpatone |
| Abiomed | $40.52 | 2019 | |
| Bardy Diagnostics, INC. | $39.75 | 2021 | |
| Heartflow, INC. | $35.89 | 2022 | |
| Medicure Pharma INC. | $27.98 | 2021 | |
| Altathera Pharmaceuticals LLC | $27.44 | 2025 | Sotalol Hydrochloride |
| Preventice Services, LLC | $22.05 | 2021 | |
| Vifor Pharma, INC. | $21.08 | 2020 | |
| Portola Pharmaceuticals, LLC | $20.30 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $19.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.66 | 2025 | |
| Currax Pharmaceuticals LLC | $17.97 | 2021 | |
| Angiodynamics, INC. | $16.68 | 2020 | |
| Baxter Healthcare | $15.47 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Amryt Pharma Holdings LTD | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Purmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.